In Treatment of Idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis is a lung disease caused by lung tissue becoming thick and stiff and eventually forming scar tissue within the lungs. The scarring, or fibrosis, seems to result from a cycle of damage and healing that occurs in the lungs. These changes are irreversible and the affected person may experience shortness of breath or dry cough as initial symptoms. Pirfact 801 Tablet reduces the scarring or fibrosis and makes breathing easier. You may experience some bothersome side effects. Discuss with your doctor if you have any doubts.
It is not known whether it is safe to consume alcohol with Pirfact 801 Tablet. Please consult your doctor.
Pirfact 801 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Pirfact 801 Tablet during breastfeeding is not available. Please consult your doctor.
Pirfact 801 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Pirfact 801 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Pirfact 801 Tablet may be needed. Please consult your doctor. Use of Pirfact 801 Tablet is not recommended with severe kidney disease and dialysis patients.
Pirfact 801 Tablet should be used with caution in patients with liver disease. Dose adjustment of Pirfact 801 Tablet may be needed. Please consult your doctor. Use of Pirfact 801 Tablet is not recommended in patients with severe liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: MSN Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Glenmark Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)